Evaluation of CGMS® during rapid blood glucose changes in patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 8, Issue 2, 2006, Pages 146-155

  Wilhelm, Birgit ^a   Forst, Senait ^a   Weber, Matthias M ^a   Larbig, Martin ^a   Pfützner, Andreas ^a   Forst, Thomas ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Institute for Clinical Research and Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO OGT; GLUCOSE; GLUCOSE OXIDASE; GLYCOSYLATED HEMOGLOBIN; INSULIN; RECOMBINANT HUMAN INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; ELECTRONIC SENSOR; EVALUATION RESEARCH; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEASUREMENT; NON INVASIVE MEASUREMENT; OPEN STUDY; PATIENT SAFETY; PRIORITY JOURNAL; RELIABILITY; SELF MONITORING; TECHNIQUE; BLOOD; BLOOD GLUCOSE MONITORING; COMPARATIVE STUDY; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; STANDARD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED;

EID: 33744941561     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.146     Document Type: Article

References (40)

1. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 1998;21(Suppl 1):523-526.
2. American Diabetes Association: Self-monitoring of blood glucose (Consensus Statement). Diabetes Care 1994;17:81-86.
3. The Diabetes Control and Complications Trial Research Group: The relationship of glycemic exposure (HbA1c) to the risk development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-983.
4. Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P: Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997;20:64-70.
5. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56.
6. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.
7. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002; 25:347-352.
8. Lutgers HL, Hullegie LM, Hoogenberg K, Sluiter WJ, Dullaart RP, Wientjes KJ, Schoonen AJ: Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in type 1 diabetic patients. Neth J Med 2000;57:7-12.
9. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000;278:E716-E728.
10. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999;277:E561-E571.
11. Wientjes KJ, Vonk P, Vonk-van Klei Y, Schoonen AJ, Kossen NW: Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care 1998;21:1481-1488.
12. Jungheim K, Koschinsky T: Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002;25:956-960.
13. Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, Horwitz DL: Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 2002;25:961-964.
14. Pfützner A, Forst T: Response to Jungheim and Koschinsky. Diabetes Care 2002;25:638-639.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002;26(Suppl 1):S4-S19.
16. Jungheim K, Koschinsky T: Risky delay of hypoglycemia detection by glucose monitoring at the arm. Diabetes Care 2001;24:1303-1306.
17. Parkes JL, Slatin SL, Pardo S, Ginsberg BH: A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143-1148.
18. American Diabetes Association: Clinical practice recommendations 1996. Diabetes Care 2003;19(Suppl 1):S1-S118.
19. Skyler JS: The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S7-S12.
20. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment on the development of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986.
21. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46: 271-286.
22. Gross TM, Mastrototaro JJ: Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S19-S26.
23. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ: Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003;26:2405-2409.
24. Dewarrat R, Caduff A, Heinemann L: Hypoglycemia warning: a simulation based on blood glucose data [abstract]. Diabetes 2003;52(Suppl 1):A92.
25. Cunningham DD, Henning TP, Shain EB, Young DF, Elstrom TA, Taylor EJ: Vacuum-assisted lancing of the forearm: an effective and less painful approach to blood glucose monitoring. Diabetes Technol Ther 2000;2:541-548.
26. Fineberg SE, Bergenstal RM, Bernstein RM, Laffel LM, Schwartz SL: Use of an automated device for alternative site blood glucose monitoring. Diabetes Care 2001;24:1217-1220.
27. Pfützner A, Hermanns N, Schroder S, Wegenstein M, Larbig M, Mondok A, Forst T, Haak T: Cross-sectional investigation on the accuracy of alternate site glucose testing using the Soft-Sense glucose meter. Swiss Med Wkly 2002;132:351-357.
28. Suzuki Y, Atsumi Y, Matusoka K: Alternative site testing increases compliance of SMBG (preliminary study of 3 years cohort trials). Diabetes Res Clin Pract 2003;59:233-234.
29. Bina DM, Anderson RL, Johnson ML, Bergenstal RM, Kendall DM: Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care 2003;26:981-985.
30. Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, Horwitz DL: Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 2002;25:961-964.
31. Jungheim K, Koschinsky T: Glucose monitoring at the thenar: evaluation of upper dermal blood glucose kinetics during rapid systemic blood glucose changes. Horm Metab Res 2002;34:325-329.
32. Rendell M, Bergman T, O'Donnell G, Drobny E, Borgos J, Bonner RF: Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes 1989;38:819-824.
33. Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes. Diabetes Care 1999;9: 1549-1554.
34. Corbin DOC, Young RJ, Morrison DC, Hoskins P, McDicken WN, Housley E, Clarke BF: Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia 1987;30:468-473.
35. Forst T, Pfutzner A, Bauersachs R, Arin M, Bach B, Biehlmaier H Kuestner E, Beyer J: Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot. J Diabetes Complications 1997;11:291-297.
36. Shami SK, Chittenden SJ: Microangiopathy in diabetes mellitus: II. Features, complications and investigation. Diabetes Res 1991;17:157-168.
37. Khodabandehlou T, Zhao H, Vimeux M, Aouane F, Le Devehat C: Haemorheological consequences of hyperglycaemic spike in healthy volunteers and insulin-dependent diabetics. Clin Hemorheol Microcirc 1998;19:105-114.
38. Forst T, Kunt T, Pohlmann T, Goitom K, Löbig M, Engelbach M, Beyer J, Pfuetzner A: Microvascular skin blood flow following the ingestion of 75g glucose in healthy individuals. Exp Clin Endocrinol Diabetes 1998;106:453-458.
39. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994;94: 2511-2515.
40. Tooke JE, Lins PE, Ostergren J, Adamson U, Fagrell B: The effects of intravenous insulin infusion on skin microcirculatory flow in Type 1 diabetes. Int J Microcirc Clin Exp 1985;4:69-83.